Despite dramatic advances in medicine, health care still causes harm too often, costs too much, and improves too slowly. This has led many payers and policy makers to focus on improving value, which includes quality, patient experience, and cost of care. Despite national attention on providing value in medicine, measures of value have been slow to emerge. We believe that professional societies have an opportunity to collaborate and develop standards that include not only outcomes but also patient experience and cost.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Dietz JR, Pronovost P. Time to Focus on Value-Based Metrics for Cancer Care? JAMA Oncol. 2020;6(9):1325–1326. doi:10.1001/jamaoncol.2020.0792
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: